IL6 and ovarian cancer: To inhibit ovarian tumor progression by targeting adipocytes, Nieman and colleagues showed that antibodies that target omental adipocytes-derived IL-6, IL-8, MCP-1, and TIMP-1 significantly reduced homing of ovarian cancer cells toward adipocytes [7].